Morphologic features of response to Gleevec (Imatinib) treatment of GIST

被引：3
|
作者：
Colecchia, M [1 ]
Diment, J [1 ]
机构：
[1] Ist Nazl Tumori, I-20133 Milan, Italy
来源：
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY | 2003年 / 11卷 / 02期
关键词：
D O I：
10.1177/106689690301100209
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [1] Treatment of inoperable gastrointestinal stromal tumor (GIST) with imatinib (Glivec®, Gleevec™)
    Joensuu, H
    MEDIZINISCHE KLINIK, 2002, 97 : 28 - 30
  • [2] FDA Grants Imatinib (Gleevec) Full Approval for Adjuvant Treatment of GIST
    不详
    ONCOLOGY-NEW YORK, 2012, 26 (03): : 264 - +
  • [3] Morphologic and molecular heterogeneity in imatinib-resistant GIST
    Liegl, B.
    Kepten, I.
    Donsky, R.
    Fletcher, C. D. M.
    Corless, C. L.
    Fletcher, J. A.
    MODERN PATHOLOGY, 2008, 21 : 14A - 14A
  • [4] Morphologic and molecular heterogeneity in imatinib-resistant GIST
    Liegl, B.
    Kepten, I.
    Donsky, R.
    Fletcher, C. D. M.
    Corless, C. L.
    Fletcher, J. A.
    LABORATORY INVESTIGATION, 2008, 88 : 14A - 14A
  • [5] Morphologic & immunohistochemical (IM) changes of gastrointestinal stromal tumors (GIST) after Gleevec treatment: A study of 16 cases
    Kim, MJ
    Jang, SJ
    Yu, E
    Kang, YG
    Ro, JY
    LABORATORY INVESTIGATION, 2006, 86 : 110A - 111A
  • [6] Morphologic & immunohistochemical (IM) changes of gastrointestinal stromal tumors (GIST) after Gleevec treatment: A study of 16 cases
    Kim, MJ
    Jang, SJ
    Yu, E
    Kang, YG
    Ro, JY
    MODERN PATHOLOGY, 2006, 19 : 110A - 111A
  • [7] FDG-PET as a surrogate marker for response to Gleevec™ (imatinib mesylate) in patients with advanced gastrointestinal stromal tumors (GIST).
    Van den Abbeele, AD
    Badawi, RD
    Tetrault, RJ
    Cliche, JP
    Manola, J
    Spangler, T
    Janicek, MJ
    Israel, DA
    Heinrich, MC
    Silberman, SS
    Dimitrijevic, S
    Demetri, GD
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 24P - 25P
  • [8] Two cases of complete response after imatinib mesylate treatment of advanced GIST
    Papaxoinis, George
    Nikolaou, Maria
    Lianos, Evangelos
    Gaglia, Asimina
    Economopoulos, Theofanis
    Pectasides, Dimitrios
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4869 - 4872
  • [9] Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients
    Valadao, Marcus
    Braggio, Danielle
    Santos, Anna Flavia
    Pimenta-Inada, Haynna Kimie
    Linhares, Eduardo
    Goncalves, Rinaldo
    Romano, Sergio
    Vilhena, Bruno
    Small, Isabele
    Cubero, Daniel
    Cruz, Felipe
    Oliveira, Antonio Talvane
    Martinho, Olga
    Reis, Rui Manuel
    Guimaraes, Denise Peixoto
    Ferreira, Carlos Gil
    JOURNAL OF SURGICAL RESEARCH, 2012, 178 (01) : 288 - 293
  • [10] IMPACT OF NEOADJUVANT TREATMENT WITH IMATINIB IN THE TREATMENT OF RECTAL GIST
    Cheong, C.
    Cho, M.
    Hur, H.
    Min, B.
    Kim, N.
    Lee, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E287 - E287
12345